Medpace vs Waters Corporation
Medpace (MEDP) and Waters Corporation (WAT) side by side: how big they are, what they earn, how their shares have moved and what insiders, members of Congress and funds reported. Figures from filings and closing prices; none of this is a view on either stock.
- Market value
- $17.1B
- Last close
- $610.54
- 12 months
- +4.2%
- Market value
- $45.5B
- Last close
- $440.45
- 12 months
- +16.3%
At a glance
- The biggest part of Medpace's revenue is Oncology (30%); at Waters Corporation it is Waters Instrument Systems (35%).
- By market value, Waters Corporation ($45.5B) is about 2.7 times Medpace ($17.1B).
- Over the last 12 months Medpace's share price moved +4.2% and Waters Corporation's +16.3%; against the S&P 500 that is −1.6 points and +10.6 points.
- In their last fiscal years Medpace kept 17.8% of revenue as net income and Waters Corporation 20.3%.
- In the last 90 days insiders reported 0 open-market purchases at Medpace and 0 at Waters Corporation; members of Congress disclosed 0 trades in Medpace and 1 in Waters Corporation.
- Next results: Medpace Feb 8, 2027, Waters Corporation Feb 8, 2027.
How each one makes money: Medpace revenue · Waters Corporation revenue
Share prices on one chart
Medpace and Waters Corporation, and up to three more you add, drawn on the same scale so you can see which moved more.
Face to face
The figures that separate the two, drawn to the same scale. Every figure is also in the table below.
Size
Market value
Revenue, last fiscal year
Net income, last fiscal year
Every figure
| Medpace MEDPNASDAQ · Life Sciences Tools & Services | Waters Corporation WATNYSE · Life Sciences Tools & Services | |
|---|---|---|
| Size and profitability | ||
| Market value | $17.1B | $45.5B |
| Revenue, last fiscal year | $2.53B | $3.17B |
| Net income, last fiscal year | $451M | $643M |
| Net marginNet income as a share of revenue | 17.8% | 20.3% |
| Free cash flow | $682M | |
Prices are end-of-day closes, and fundamentals are the companies' last annual figures from their SEC filings: a − or + in the table is a fact of the filing or the close, not a forecast. Market value is the company-level figure at the last close. Counts are of records OQRO holds, by their date; insider history since 2006 comes from the SEC's insider transactions data sets and every filing since. Planned sales under a 10b5-1 plan are counted like other sales.
Compare with another company
Waters Corporation against
Common questions
How is Medpace different from Waters Corporation?
Medpace (MEDP) is in Life Sciences Tools & Services on NASDAQ, with $2.53B of revenue in its last fiscal year and a net margin of 17.8%. Waters Corporation (WAT) is in Life Sciences Tools & Services on NYSE, with $3.17B of revenue in its last fiscal year and a net margin of 20.3%. The biggest part of Medpace's revenue is Oncology (30%); at Waters Corporation it is Waters Instrument Systems (35%). The table above sets their figures side by side; it compares filings and is not a view on either stock.
How do Medpace and Waters Corporation compare in size?
Waters Corporation has the larger market value: Medpace $17.1B and Waters Corporation $45.5B, at the last close.
Whose share price rose more over the last 12 months, MEDP or WAT?
Over the last 12 months Medpace moved +4.2% and Waters Corporation +16.3%. Past price moves say nothing about the future.
Which has had more insider buying, Medpace or Waters Corporation?
Since 2006, Medpace insiders reported 40 open-market purchases against 5 for Waters Corporation. These are counts of what was filed, not a view on either stock.
Do members of Congress trade MEDP or WAT?
In the last 12 months, members of Congress disclosed 6 trades in Medpace (MEDP) and 9 in Waters Corporation (WAT).
When did insiders last buy MEDP and WAT?
See the record behind any of these
A free account opens the full history of every insider and company since 2006, the screener, alerts, Congress trades and fund moves.
Medpace pageWaters Corporation pageRare insider trades this weekAll comparisons
https://oqro.io/compare/medp-vs-wat







